Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents

[1] Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Implantation: Insights from the SEEDS Study[J] . Yao-Jun Zhang,Ye-Lin Zhao,Bo Xu,Ya-Ling Han,Bao Li,Qiang Liu,Xi Su,Si Pang,Shu-Zheng Lu,Xiao-Feng Guo,Yue-Jin Yang.Chinese Medical Journal . 2015 (6)

[2] Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI[J] . Levine Glenn N,Jeong Young-Hoon,Goto Shinya,Anderson Jeffrey L,Huo Yong,Mega Jessica L,Taubert Kathryn,Smith Sidney C.Nature reviews. Cardiology . 2014 (10)

[3] Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy[J] . Antonio Colombo,Alaide Chieffo,Arian Frasheri,Roberto Garbo,Monica Masotti,Neus Salvatella,Juan Francisco Oteo Dominguez,Luigi Steffanon,Giuseppe Tarantini,Patrizia Presbitero,Alberto Menozzi,Edoardo Pucci,Josefina Mauri,Bruno Mario Cesana,Gennaro Giustino,Gennaro Sardella.Journal of the American College of Cardiology . 2014

[4] Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1932 - 1948

[5] Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1949 - +

[6] Balancing ischaemia and bleeding with dual antiplatelet therapy: a resolute endeavour [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1914 - 1916

[7] Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome [J]. EUROPEAN HEART JOURNAL, 2014, 35 (15) : 969 - +

[8] Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer‐Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE Study[J] . LEI ZHANG,YI LI,QUAN‐MIN JING,XIAO‐ZENG WANG,YING‐YAN MA,GENG WANG,BO XU,RUN‐LIN GAO,YA‐LING HAN.J. Int. Cardiol. . 2014 (2)

[9] Meta-Analysis of Randomized Clinical Trials Comparing Short-Term Versus Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents[J] . Georges El-Hayek,Franz Messerli,Sripal Bangalore,Mun K. Hong,Eyal Herzog,Alexandre Benjo,Jacqueline E. Tamis-Holland.The American Journal of Cardiology . 2014

[10] A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial[J] . Gao Run-Lin,Xu Bo,Lansky Alexandra J,Yang Yue-Jin,Ma Chang-Sheng,Han Ya-Ling,Chen Shao-Liang,Li Hui,Zhang Rui-Yan,Fu Guo-Sheng,Yuan Zu-Yi,Jiang Hong,Huo Yong,Li Wei,Zhang Yao-Jun,Leon Martin B.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Intervent

[1] Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Implantation: Insights from the SEEDS Study[J] . Yao-Jun Zhang,Ye-Lin Zhao,Bo Xu,Ya-Ling Han,Bao Li,Qiang Liu,Xi Su,Si Pang,Shu-Zheng Lu,Xiao-Feng Guo,Yue-Jin Yang.Chinese Medical Journal . 2015 (6)

[2] Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI[J] . Levine Glenn N,Jeong Young-Hoon,Goto Shinya,Anderson Jeffrey L,Huo Yong,Mega Jessica L,Taubert Kathryn,Smith Sidney C.Nature reviews. Cardiology . 2014 (10)

[3] Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy[J] . Antonio Colombo,Alaide Chieffo,Arian Frasheri,Roberto Garbo,Monica Masotti,Neus Salvatella,Juan Francisco Oteo Dominguez,Luigi Steffanon,Giuseppe Tarantini,Patrizia Presbitero,Alberto Menozzi,Edoardo Pucci,Josefina Mauri,Bruno Mario Cesana,Gennaro Giustino,Gennaro Sardella.Journal of the American College of Cardiology . 2014

[4] Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1932 - 1948

[5] Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1949 - +

[6] Balancing ischaemia and bleeding with dual antiplatelet therapy: a resolute endeavour [J]. EUROPEAN HEART JOURNAL, 2014, 35 (29) : 1914 - 1916

[7] Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome [J]. EUROPEAN HEART JOURNAL, 2014, 35 (15) : 969 - +

[8] Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer‐Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE Study[J] . LEI ZHANG,YI LI,QUAN‐MIN JING,XIAO‐ZENG WANG,YING‐YAN MA,GENG WANG,BO XU,RUN‐LIN GAO,YA‐LING HAN.J. Int. Cardiol. . 2014 (2)

[9] Meta-Analysis of Randomized Clinical Trials Comparing Short-Term Versus Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents[J] . Georges El-Hayek,Franz Messerli,Sripal Bangalore,Mun K. Hong,Eyal Herzog,Alexandre Benjo,Jacqueline E. Tamis-Holland.The American Journal of Cardiology . 2014

[10] A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial[J] . Gao Run-Lin,Xu Bo,Lansky Alexandra J,Yang Yue-Jin,Ma Chang-Sheng,Han Ya-Ling,Chen Shao-Liang,Li Hui,Zhang Rui-Yan,Fu Guo-Sheng,Yuan Zu-Yi,Jiang Hong,Huo Yong,Li Wei,Zhang Yao-Jun,Leon Martin B.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Intervent